Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0215|137|10|2454-2461

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.137, Iss.10, 2015-11, pp. : 2454-2461

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetic variants in TNF‐α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 134, Iss. 8, 2014-04 ,pp. : 1907-1915

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inflammation‐Related Genetic Variants Predict Toxicity Following Definitive Radiotherapy for Lung Cancer

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 5, 2014-11 ,pp. : 609-615

John Wiley & Sons Inc

Access to resources Recommend Favorite

Definitive radiotherapy for cervical esophageal cancer

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 2, 2015-02 ,pp. : 151-155

John Wiley & Sons Inc

Access to resources Recommend Favorite

Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer

By  

CANCER, Vol. 121, Iss. 15, 2015-08 ,pp. : 2603-2611

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of obesity on outcomes after definitive dose‐escalated intensity‐modulated radiotherapy for localized prostate cancer

By  

CANCER, Vol. 121, Iss. 17, 2015-09 ,pp. : 3010-3017

John Wiley & Sons Inc

Access to resources Recommend Favorite